Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Every meal
If it is linked to absorption issues, ongoing treatment may be required
Independent testing has found that many so-called BPC-157 products do not actually contain the compound, or contain it in impure forms that could be contaminated with other substances
BPC 157 entered early-phase clinical development for inflammatory bowel disease as PL 14736 (Pliva, Croatia), and a 2025 pilot examined intravenous administration in a small cohort, but no adequately powered randomised controlled trial exists
Because of this, BPC-157 should be viewed within the broader context of experimental peptide research rather than as a fully established intervention
Neither BPC-157 nor TB-500 is a controlled substance in the UK
US$ 27.94
US$ 24.12
US$ 26.24
US$ 23.80
US$ 23.70
US$ 26.21
US$ 28.41
US$ 20.85
US$ 20.89
US$ 27.82
